Not-to-be-missed webinar takes place next week
18 April 2024A reminder that a not-to-be-missed webinar takes place next week! Candesic Senior Partner Dr Michelle Tempest will be kicking off the Royal Society of…PHIN Private market update: March 2024
17 April 2024The latest private market update from Private Healthcare Information Network (PHIN) makes for interesting reading. Comparing quarter for quarter with the latest available…The UK FemTech powerhouse
15 April 2024The UK is poised to challenge the US as a powerhouse in FemTech, the burgeoning sector leveraging technology to address women’s…Welcome to the Candesic team
11 April 2024Candesic continues to attract some of the brightest and best new recruits. We are delighted to introduce our new interns Christian Oldfield, Obioma Chima,…
Does SEN safeguarding provision go far enough?
8 April 2024When the parents and carers of the UK's 1.5m children with special educational needs (SEN) drop them off at school…Dynamic FemTech market
27 March 2024Candesic Senior Partner Dr Michelle Tempest and Alina Trabattoni have been speaking to leaders in the FemTech market for a piece due to be published…Deal or no deal?
21 March 2024Deal or no deal? In 2023, the answer was often ‘deal’! Over US$ 84 billion worth of deals were closed…
Private Equity is transforming European smiles
12 March 2024The European dental market is increasingly attracting interest, and cosmetic dentistry in particular is booming, especially on the orthodontic and…Results of the NHS Staff Survey 2023
11 March 2024What did you make of the results of the NHS Staff Survey 2023, which was published at the end of last week?…Rise of the organoids
28 February 2024Candesic Managing Partner Dr Leonid Shapiro and Principal Dr Joe Taylor explore the intriguing applications of cerebral organoids in the latest edition of PharmaTimes. These artificially…
